Abstract
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have